Insulin is being increasingly demanded with increasing diabetic cases

Insulin Market

Definition

Insulin refers to a peptide hormone produced by beta cells of the pancreatic islets; it is considered to be the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of glucose from the blood into liver, fat and skeletal muscle cells.

Drivers & Restraints

Insulin market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of market.

Sample Link Here: https://www.asamarketresearch.com/request-sample/998399

Segments-

Product-

Rapid acting

Long acting

Premixed

Premixed analog

Short acting

Intermedi ate acting

Source-

Human Recombinant Insulin

Analogs

Application-

Type I Diabetes

Type II Diabetes and Others

Regional Analysis

The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC.

Purchase Link Here: https://www.asamarketresearch.com/checkout/998399

Companies-

Eli Lilly

Sanofi

Novartis

Takeda Pharmaceuticals

Oramed Pharmaceuticals

Novo Nordisk

Dongbao Enterprise Group Co., Ltd.

Bristol-Myers Squibb

Biocon